Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis-Reference-Cited by-同舟云学术

Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis

Published:2022-07-18 Issue:11 Volume:43 Page:6271-6278
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Pastor Bandeira Isabelle^ORCID,de Almeida Franzoi André Eduardo^ORCID,Murillo Wollmann Giulia^ORCID,de Medeiros Junior Washigton Luiz Gomes^ORCID,Nogueira Brandão Wesley^ORCID,Schatzmann Peron Jean Pierre^ORCID,Becker Jefferson^ORCID,Nascimento Osvaldo José Moreira^ORCID,Magno Gonçalves Marcus Vinícius^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-022-06276-5.pdf

Reference74 articles.

1. Garg N, Smith T (2015) An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav 5(9):n/a-n/a. https://doi.org/10.1002/brb3.362

2. Gelfand J. (2014) Multiple sclerosis. Handb clin neurol 269–290. ISBN: 978–0–444–52001–2

3. Lemus H, Warrington A, Rodriguez M (2018) Multiple sclerosis. Neurologic Clinics 36(1):1–11 https://doi.org/10.1016/j.ncl.2017.08.002

4. McMahon E, Bailey S, Castenada C, Waldner H, Miller S (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11(3):335–339. https://doi.org/10.1038/nm1202

5. Rothhammer V, Heink S, Petermann F, Srivastava R, Claussen M, Hemmer B, Korn T (2011) Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J Exp Med 208(12):2465–2476. https://doi.org/10.1084/jem.20110434

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble CD40 Ligand as a Promising Biomarker in Cancer Diagnosis;Cells;2024-07-28

2. Interleukin (IL)-23, IL-31, and IL-33 Play a Role in the Course of Autoim-mune Endocrine Diseases;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-04

3. Biomarkers in Multiple Sclerosis: Analysis of the Present Advantages and Look to the Future;Journal of Psychology and Neuroscience;2023-07-19

4. Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy;Journal of Clinical Medicine;2023-03-03